Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Counselor Presents Revolutionary Approach to Treating Addiction in New Book
  • USA - English


News provided by

LAVIDGE

Jun 17, 2019, 08:00 ET

Share this article

Share toX

Share this article

Share toX


There’s no reason to prolong our national addiction nightmare. There’s no reason to substitute one narcotic for another and call it therapy.

Post this

SPRINGFIELD, La. (PRWEB) June 17, 2019 -- Counselor and trailblazer in the field of chemical dependency treatment Paula Norris Mestayer has published her remarkable story of discovering and further developing a groundbreaking approach to treating the brain disease of addiction. In “Addiction: The Dark Night of the Soul/NAD+: the Light of Hope,” Mestayer shares her 20 years of clinical experience delivering intravenous infusions of NAD+ – a natural coenzyme of niacin – to help her patients kick opiates, alcohol and other addictive substances with minimal withdrawal symptoms or cravings and without substituting another addictive narcotic.

As the U.S. opioid epidemic grows increasingly dire, Mestayer’s work provides a critically needed solution so that many more can find their way back to health, wholeness and freedom once again. Mestayer was originally introduced to the treatment when she sought help for her own daughter’s addiction, and the paradigm-shifting results she observed inspired her to begin offering NAD+ to others who came to her therapy practice seeking guidance.

“Addiction: The Dark Night of the Soul” also explores how the treatment has been beneficial in the brain restoration process to people with depression and post-traumatic stress disorder as well as to those who have neurodegenerative disorders like Alzheimer’s, Parkinson’s and chronic traumatic encephalopathy.

“When you finish reading, I hope you’ll become an ambassador for a conversation that can change the course of neurodegenerative diseases and addiction treatment in our country,” Mestayer wrote in the preface of her book. “There’s no reason to prolong our national addiction nightmare. There’s no reason to substitute one narcotic for another and call it therapy.”

Ultimately, “Addiction: The Dark Night of the Soul” presents a viable answer to an epidemic that has consumed the U.S. without prejudice. With the opioid crisis now declared a public health emergency, important steps must be taken to address the toll of addiction. Mestayer’s book supports this and calls for reconsideration of traditionally accepted addiction treatment and rehab standards, which she says have not truly treated the damage caused to a person’s brain after experiencing addiction.

“I'd known about this newer technology for some time and then assisted someone to attend Springfield Wellness. I observed some of what is documented within in these pages in ‘progress’ and could not be more grateful, impressed or hopeful about the advances that are taking place in this field,” a reader wrote in a five-star review of “Addiction: The Dark Night of the Soul” on Amazon. “There IS Hope. Paula Norris Mestayer has truly held up a lamp into the darkness.”

“Addiction: The Dark Night of the Soul/NAD+: The Light of Hope”
By Paula Norris Mestayer with Leslee Goodman
ISBN: 978-1-9822-1815-7 (hardcover); 978-1-9822-1813-3 (softcover);
978-1-9822-1814-0 (e-book)
Available through Balboa Press, Barnes & Noble and Amazon

About the Author
Paula Norris Mestayer is a Licensed Professional Counselor, a Fellow of the American Psychotherapy Association and a member of the American Counseling Association and the Louisiana Counseling Association. Mestayer was an educator for 11 years after graduating from Louisiana State University in 1969. She completed graduate degrees in education and independent study in psychotherapy from Tulane University before taking her clinical internship at the Manhattan Children’s Psychiatric Hospital. Mestayer has devoted her professional life to helping patients deal effectively with a wide variety of sub-acute psycho-physiological conditions, including panic and anxiety disorders, chronic and acute stress, depression and bereavement, alcohol and substance abuse and marital and family challenges. For 22 years she was a consultant at Ochsner Foundation Hospital with the Behavioral Health and Addiction Treatment Units. Concurrently, 11 of those years she was the director of a private nonprofit residential program for abused and neglected children. In 2001, she founded an outpatient clinic providing services for the treatment of chemical dependency and acute stress utilizing intravenous infusions, which then led to the development of BR+NAD at Springfield Wellness Center. The clinic is the longest operating NAD+ IV clinic in the U.S., and it pioneered the BR+NAD methods and protocols. Mestayer was certified by the International Society of Clinical Hypnosis, the New Orleans Society of Clinical Hypnosis, the PAIRS Foundation for Marital Family Therapy and the ADTR-Creative Arts Therapy. She currently resides with her loving husband, Dr. Richard Mestayer, III, horses, dogs, chickens, ducks, cat, donkey and visiting children and grandchildren in Natchez, Miss. To learn more, please visit http://www.addictionthedarknightofthesoul.com and listen to Mestayer’s interview on Hay House Radio.

General Inquiries, Review Copies & Interview Requests:
LAVIDGE – Phoenix
Danielle Grobmeier
480-648-7557
dgrobmeier(at)lavidge.com

Danielle Grobmeier, LAVIDGE, 480-648-7557, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.